Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Epiroc A EPIA Apr 25, 2025 206.00 +1.43   
 Epiroc B EPIB Apr 25, 2025 182.70 +1.50   
 Episurf Medical B EPISB Apr 25, 2025 0.12 -0.66   
 EQL Pharma EQL Apr 25, 2025 79.00 +0.16   
 EQT EQT Apr 25, 2025 272.50 +1.38   
 Ericsson A ERICA Apr 25, 2025 80.20 +1.26   
 Ericsson B ERICB Apr 25, 2025 79.88 +0.81   
 ES Energy Save Holding ESGRB Apr 25, 2025 20.00 -5.66   
 Essity A ESSITYA Apr 25, 2025 271.50 0.00   
 Essity B ESSITYB Apr 25, 2025 270.40 -0.11   
 Eurobattery Minerals BAT Apr 25, 2025 0.06 +11.54   
 Everysport Group AB EVERY Apr 25, 2025 19.20 +0.52   
 Evolear AB EVOL Apr 25, 2025 1.65 -2.94   
 Evolution EVO Apr 25, 2025 825.40 +1.13   
 Ework Group AB. EWRK Apr 25, 2025 141.08 +1.58   
 Exalt EXALT Apr 25, 2025 0.46 0.00   
 ExpreS2ion Biotech Holding EXPRS2 Apr 25, 2025 19.50 0.00   
 Exsitec EXS Apr 25, 2025 119.00 -1.65   
 Eyeonid Group EOID Apr 25, 2025 19.00 +8.82   
 Fabege FABG Apr 25, 2025 81.85 -0.79   
 Fable Media Group AB FABLE Apr 25, 2025 5.04 -4.91   
 Fagerhult Group AB FAG Apr 25, 2025 43.45 +0.58   
 Fasadgruppen FG Apr 25, 2025 19.56 +2.19   
 Fastator FASTAT Apr 25, 2025 1.35 +2.43   
 Fastpartner A FPARA Apr 25, 2025 52.06 +5.17   
 Fastpartner D FPARD Apr 25, 2025 71.60 +0.85   
 Fenix Outdoor B FOIB Apr 25, 2025 600.00 +1.52   
 Ferroamp AB FERRO Apr 25, 2025 2.15 +0.94   
 Ferronordic FNM Apr 25, 2025 47.10 +4.78   
 Finepart FINE Apr 25, 2025 0.23 +5.86   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.